HTLS 2020: Dr Ashish Jha asks people not to worry about long-term immunity from Covid-19

- Advertisement -

Dr Ashish K Jha, Dean, Brown University School of Public Health on Thursday said that data and research done on immunity from Covid-19 has been reassuring and said that expecting a lifelong 100% immunity from the coronavirus is unrealistic, in conversation with Hindustan Times editor-in-chief Sukumar Ranganathan during the inaugural session of the 18th Hindustan Times Leadership Summit.

Jha said, “Immunity is complicated. We know that across the world 50-60 million people have been infected with the virus. There have been reinfections two months after the initial infection but those are very uncommon.”

WATCH | ‘2 phases of Covid…’: How our coronavirus understanding evolved #HTLS2020

He also said that lifelong immunity from any virus is not a realistic expectation. He said people can expect to be immune for at least ‘a year or longer.’ Jha said that the findings show that people who have recovered from Covid-19 have gained immunity for eight or nine months, barring a few exceptions.

Jha pointed out that the medical and scientific community do not have huge amounts of experience in dealing with SARS-Cov-2 as it is relatively new. He said that people should also not worry themselves with studies concerning antibodies.

He highlighted that immunity will be closely studied as Covid-19 vaccines are rolled out. He said, “Immunity (gained) looks like it remains durable for 8-9 months. At this point, I can be betting that most people may remain immune for at least one year… Based on all of that my guess right now is but we have to get a booster shot every year, that’s okay, it is not great. It may last longer, we do not know.”

Also Read| HTLS 2020: Is India ready for another pandemic? AIIMS director Dr Guleria answers

Jha advised people not to look into the headlines and said that he himself does not worry about immunity.

The 18th Hindustan Times Leadership Summit’s inaugural session was also attended by All India Institute of Medical Sciences director Dr Randeep Guleria and chief executive officer of the Serum Institute of India Adar Poonawalla who discussed Covid-19, the vaccine race and the way forward for healthcare in India.

Disclaimer: This post has not been edited by our staff and is published from a syndicated feed. The Original Source of this post can be found at Source link

- Advertisement -


Please enter your comment!
Please enter your name here

- Advertisement -


Cops in net as anti-drug drive intensifies in northeast

At least a dozen police personnel in Arunachal Pradesh and Assam have been arrested since March In May...

Snag halts power generation at KKNPP

The power generation from the second reactor at the Kudankulam Nuclear Power Plant (KKNPP) has been suspended due to "technical snag" in one of...

Covid-19 | U.S. sends Taiwan 2.5 million vaccine doses, tripling pledge

The U.S. donation also signals its support for Taiwan in the face of growing pressure from China, which claims the self-governing island off its...
- Advertisement -

More Articles

- Advertisement -